Acinar adenocarcinoma
Acinar adenocarcinoma is a type of cancer that originates from the acinar cells of the exocrine glands. These glands are responsible for producing and secreting substances such as saliva, sweat, and digestive enzymes. Acinar adenocarcinoma is most commonly found in the pancreas, but can also occur in other organs such as the salivary glands, lungs, and prostate.
Etiology
The exact cause of acinar adenocarcinoma is not known. However, several risk factors have been identified, including smoking, chronic pancreatitis, and certain genetic conditions such as hereditary pancreatitis and Peutz-Jeghers syndrome.
Pathophysiology
Acinar adenocarcinoma develops when the DNA of acinar cells becomes damaged or altered. These genetic changes can cause the cells to grow and divide uncontrollably, leading to the formation of a tumor. Over time, the tumor can invade nearby tissues and spread to other parts of the body through the lymphatic system or bloodstream.
Clinical Presentation
The symptoms of acinar adenocarcinoma can vary depending on the location of the tumor. Common symptoms include abdominal pain, jaundice, weight loss, and digestive problems. If the tumor is located in the pancreas, it may also cause diabetes.
Diagnosis
Diagnosis of acinar adenocarcinoma typically involves a combination of physical examination, imaging tests such as computed tomography (CT) scans and magnetic resonance imaging (MRI), and biopsy. The definitive diagnosis is usually made by examining a sample of the tumor under a microscope.
Treatment
Treatment for acinar adenocarcinoma depends on the stage of the disease, the patient's overall health, and the location of the tumor. Options may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.
Prognosis
The prognosis for acinar adenocarcinoma varies widely depending on the stage of the disease at diagnosis, the patient's overall health, and the effectiveness of treatment. Early detection and treatment can significantly improve the prognosis.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD